Septerna (SEPN) shares sank 59% amid heavy trading after the company said Tuesday it discontinued a phase 1 clinical trial of SEP-786 to treat hypoparathyroidism in healthy volunteers.
Intraday trading volume soared to nearly 6.27 million shares from a daily average of about 313,000.
Greenlane Holdings (GNLN) said Tuesday it struck deals to sell about $25.0 million of shares and investor warrants at $1.19 per unit to institutional investors.
Shares sank 37%, with intraday trading volume catapulting to over 2.92 million versus a daily average of about 122,000.
Medtronic (MDT) reported fiscal Q3 revenue below analyst projections as some distributors cut surgical inventory levels, weighing on the division's performance.
Shares slid 6.5% as intraday trading volume rose to over 8.32 million from the stock's daily average of about 6.7 million.
Price: 5.37, Change: -7.59, Percent Change: -58.56
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.